Stifel Financial’s vTv Therapeutics VTVT Stock Holding History

Stifel Financial’s Portfolio VTVT Stock Details VTVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-818	Closed	-$157K	–	2608
2016 Q4	$157K	Buy	+818	New	+$188K	﹤0.01%	2307

Other funds holding VTVT

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Stifel Financial's VTVT Position: Q1 2017 in Review

Stifel Financial sold out of vTv Therapeutics (VTVT) in Q1 2017, closing a stake of 818 shares — an estimated $157K sold.

Stifel Financial first reported a position in VTVT in Q4 2016 and held it in 1 quarter. The position peaked at $157K in Q4 2016. 41 funds tracked by Wall St. Rank hold VTVT as of Q1 2017.

Stifel Financial reported no remaining vTv Therapeutics position as of Q1 2017 after selling out during the quarter.
Stifel Financial sold 818 vTv Therapeutics shares in Q1 2017, an estimated $157K.
Stifel Financial first reported a position in vTv Therapeutics in Q4 2016 and held it in 1 quarter.
Stifel Financial's vTv Therapeutics position peaked at $157K in Q4 2016.
41 funds tracked by Wall St. Rank held vTv Therapeutics as of Q1 2017.

Based on Stifel Financial's 13F filing for Q1 2017, filed 10 May 2017.